JP2013530206A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013530206A5 JP2013530206A5 JP2013517480A JP2013517480A JP2013530206A5 JP 2013530206 A5 JP2013530206 A5 JP 2013530206A5 JP 2013517480 A JP2013517480 A JP 2013517480A JP 2013517480 A JP2013517480 A JP 2013517480A JP 2013530206 A5 JP2013530206 A5 JP 2013530206A5
- Authority
- JP
- Japan
- Prior art keywords
- dosage form
- pharmaceutical dosage
- fcf
- chemical
- particles
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000002552 dosage form Substances 0.000 claims 13
- 239000000126 substance Substances 0.000 claims 13
- 239000002245 particle Substances 0.000 claims 9
- 238000000034 method Methods 0.000 claims 8
- SGHZXLIDFTYFHQ-UHFFFAOYSA-L Brilliant Blue Chemical compound [Na+].[Na+].C=1C=C(C(=C2C=CC(C=C2)=[N+](CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=2C(=CC=CC=2)S([O-])(=O)=O)C=CC=1N(CC)CC1=CC=CC(S([O-])(=O)=O)=C1 SGHZXLIDFTYFHQ-UHFFFAOYSA-L 0.000 claims 5
- 239000004214 Fast Green FCF Substances 0.000 claims 4
- RZSYLLSAWYUBPE-UHFFFAOYSA-L Fast green FCF Chemical compound [Na+].[Na+].C=1C=C(C(=C2C=CC(C=C2)=[N+](CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=2C(=CC(O)=CC=2)S([O-])(=O)=O)C=CC=1N(CC)CC1=CC=CC(S([O-])(=O)=O)=C1 RZSYLLSAWYUBPE-UHFFFAOYSA-L 0.000 claims 4
- OIQPTROHQCGFEF-QIKYXUGXSA-L Sunset Yellow FCF Chemical compound [Na+].[Na+].OC1=CC=C2C=C(S([O-])(=O)=O)C=CC2=C1\N=N\C1=CC=C(S([O-])(=O)=O)C=C1 OIQPTROHQCGFEF-QIKYXUGXSA-L 0.000 claims 4
- CQPFMGBJSMSXLP-UHFFFAOYSA-M acid orange 7 Chemical compound [Na+].OC1=CC=C2C=CC=CC2=C1N=NC1=CC=C(S([O-])(=O)=O)C=C1 CQPFMGBJSMSXLP-UHFFFAOYSA-M 0.000 claims 4
- 239000004480 active ingredient Substances 0.000 claims 4
- 235000012745 brilliant blue FCF Nutrition 0.000 claims 4
- 239000004161 brilliant blue FCF Substances 0.000 claims 4
- 229940055580 brilliant blue fcf Drugs 0.000 claims 4
- 239000003086 colorant Substances 0.000 claims 4
- IINNWAYUJNWZRM-UHFFFAOYSA-L erythrosin B Chemical compound [Na+].[Na+].[O-]C(=O)C1=CC=CC=C1C1=C2C=C(I)C(=O)C(I)=C2OC2=C(I)C([O-])=C(I)C=C21 IINNWAYUJNWZRM-UHFFFAOYSA-L 0.000 claims 4
- 235000019240 fast green FCF Nutrition 0.000 claims 4
- 229960003988 indigo carmine Drugs 0.000 claims 4
- KHLVKKOJDHCJMG-QDBORUFSSA-L indigo carmine Chemical compound [Na+].[Na+].N/1C2=CC=C(S([O-])(=O)=O)C=C2C(=O)C\1=C1/NC2=CC=C(S(=O)(=O)[O-])C=C2C1=O KHLVKKOJDHCJMG-QDBORUFSSA-L 0.000 claims 4
- 235000012738 indigotine Nutrition 0.000 claims 4
- 239000004179 indigotine Substances 0.000 claims 4
- 239000000203 mixture Substances 0.000 claims 4
- 210000000214 mouth Anatomy 0.000 claims 4
- TVRGPOFMYCMNRB-UHFFFAOYSA-N quinizarine green ss Chemical compound C1=CC(C)=CC=C1NC(C=1C(=O)C2=CC=CC=C2C(=O)C=11)=CC=C1NC1=CC=C(C)C=C1 TVRGPOFMYCMNRB-UHFFFAOYSA-N 0.000 claims 4
- 235000012751 sunset yellow FCF Nutrition 0.000 claims 4
- 239000004173 sunset yellow FCF Substances 0.000 claims 4
- 235000012756 tartrazine Nutrition 0.000 claims 4
- 239000004149 tartrazine Substances 0.000 claims 4
- UJMBCXLDXJUMFB-GLCFPVLVSA-K tartrazine Chemical compound [Na+].[Na+].[Na+].[O-]C(=O)C1=NN(C=2C=CC(=CC=2)S([O-])(=O)=O)C(=O)C1\N=N\C1=CC=C(S([O-])(=O)=O)C=C1 UJMBCXLDXJUMFB-GLCFPVLVSA-K 0.000 claims 4
- 229960000943 tartrazine Drugs 0.000 claims 4
- -1 alphazurin FG Chemical compound 0.000 claims 3
- 239000003795 chemical substances by application Substances 0.000 claims 3
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 claims 2
- 239000000654 additive Substances 0.000 claims 2
- 235000013361 beverage Nutrition 0.000 claims 2
- 239000011248 coating agent Substances 0.000 claims 2
- 238000000576 coating method Methods 0.000 claims 2
- 239000003605 opacifier Substances 0.000 claims 2
- 239000006191 orally-disintegrating tablet Substances 0.000 claims 2
- 239000007787 solid Substances 0.000 claims 2
- 239000003826 tablet Substances 0.000 claims 2
- 239000002253 acid Substances 0.000 claims 1
- 230000000996 additive effect Effects 0.000 claims 1
- 229940035676 analgesics Drugs 0.000 claims 1
- 239000000730 antalgic agent Substances 0.000 claims 1
- 239000002249 anxiolytic agent Substances 0.000 claims 1
- 230000000949 anxiolytic effect Effects 0.000 claims 1
- 229940005530 anxiolytics Drugs 0.000 claims 1
- 239000002775 capsule Substances 0.000 claims 1
- 150000005829 chemical entities Chemical class 0.000 claims 1
- 239000007910 chewable tablet Substances 0.000 claims 1
- 150000001875 compounds Chemical class 0.000 claims 1
- 239000003085 diluting agent Substances 0.000 claims 1
- 239000007884 disintegrant Substances 0.000 claims 1
- 239000007919 dispersible tablet Substances 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 229940079593 drug Drugs 0.000 claims 1
- 239000007938 effervescent tablet Substances 0.000 claims 1
- 235000012732 erythrosine Nutrition 0.000 claims 1
- 239000004174 erythrosine Substances 0.000 claims 1
- 229940011411 erythrosine Drugs 0.000 claims 1
- 239000010408 film Substances 0.000 claims 1
- 239000000796 flavoring agent Substances 0.000 claims 1
- 235000019634 flavors Nutrition 0.000 claims 1
- GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 claims 1
- 239000007850 fluorescent dye Substances 0.000 claims 1
- 235000003599 food sweetener Nutrition 0.000 claims 1
- 239000003326 hypnotic agent Substances 0.000 claims 1
- 230000000147 hypnotic effect Effects 0.000 claims 1
- 229960004657 indocyanine green Drugs 0.000 claims 1
- MOFVSTNWEDAEEK-UHFFFAOYSA-M indocyanine green Chemical compound [Na+].[O-]S(=O)(=O)CCCCN1C2=CC=C3C=CC=CC3=C2C(C)(C)C1=CC=CC=CC=CC1=[N+](CCCCS([O-])(=O)=O)C2=CC=C(C=CC=C3)C3=C2C1(C)C MOFVSTNWEDAEEK-UHFFFAOYSA-M 0.000 claims 1
- 150000002632 lipids Chemical class 0.000 claims 1
- 239000000314 lubricant Substances 0.000 claims 1
- 239000000463 material Substances 0.000 claims 1
- 238000012856 packing Methods 0.000 claims 1
- 229920000642 polymer Polymers 0.000 claims 1
- 239000000843 powder Substances 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
- 239000000932 sedative agent Substances 0.000 claims 1
- 229940125723 sedative agent Drugs 0.000 claims 1
- 239000006190 sub-lingual tablet Substances 0.000 claims 1
- 239000003765 sweetening agent Substances 0.000 claims 1
- 239000010409 thin film Substances 0.000 claims 1
- 239000004408 titanium dioxide Substances 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR1055490 | 2010-07-06 | ||
| FR1055490A FR2962550B1 (fr) | 2010-07-06 | 2010-07-06 | Methode pour lutter contre la soumission chimique, utilisation d'agent colorant pour lutter contre la soumission chimique et composition pharmaceutique permettant la mise en oeuvre de la methode |
| PCT/FR2011/051600 WO2012010765A1 (fr) | 2010-07-06 | 2011-07-05 | Methode et agent pour la detection de drogues dans les boisson |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2013530206A JP2013530206A (ja) | 2013-07-25 |
| JP2013530206A5 true JP2013530206A5 (enExample) | 2014-08-21 |
| JP5916723B2 JP5916723B2 (ja) | 2016-05-11 |
Family
ID=43587415
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013517480A Active JP5916723B2 (ja) | 2010-07-06 | 2011-07-05 | 飲料中の薬物を検出するための方法および薬剤 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20130098286A1 (enExample) |
| EP (1) | EP2591350B1 (enExample) |
| JP (1) | JP5916723B2 (enExample) |
| KR (2) | KR20130091321A (enExample) |
| CN (1) | CN103119435A (enExample) |
| AU (1) | AU2011281482B2 (enExample) |
| CA (1) | CA2802402A1 (enExample) |
| ES (1) | ES2609831T3 (enExample) |
| FR (1) | FR2962550B1 (enExample) |
| IL (1) | IL223886B (enExample) |
| MX (1) | MX344783B (enExample) |
| WO (1) | WO2012010765A1 (enExample) |
| ZA (1) | ZA201300099B (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104237224A (zh) * | 2014-10-14 | 2014-12-24 | 厦门奥亚仪器有限公司 | 苯二氮卓的快速检测方法及其操作器皿组合 |
| US20220202742A1 (en) * | 2019-05-07 | 2022-06-30 | Clexio Biosciences Ltd. | Dosage forms for preventing drug-facilitated assault |
| US20220175719A1 (en) * | 2020-10-24 | 2022-06-09 | Mason Cave | Dissolvable thc beverage tablet production method |
| US20220241238A1 (en) * | 2020-10-24 | 2022-08-04 | Michael Roth | Method for forming a beverage with a dissolvable thc tablet |
| CN115112582B (zh) * | 2022-05-19 | 2024-08-09 | 西南科技大学 | 一种去甲芬太尼及芬太尼的检测试剂盒及其检测方法 |
| CN117654708A (zh) * | 2023-10-16 | 2024-03-08 | 杭州德望纳米科技有限公司 | 一种基于球磨实验改变蛇纹石粒度分级方法 |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1157662A (en) * | 1966-08-08 | 1969-07-09 | Codex S A | Improvements in or relating to Pharmaceutical Compositions |
| FR2679451B1 (fr) | 1991-07-22 | 1994-09-09 | Prographarm Laboratoires | Comprime multiparticulaire a delitement rapide. |
| US6649186B1 (en) * | 1996-09-20 | 2003-11-18 | Ethypharm | Effervescent granules and methods for their preparation |
| FR2766089B1 (fr) | 1997-07-21 | 2000-06-02 | Prographarm Lab | Comprime multiparticulaire perfectionne a delitement rapide |
| US5948440A (en) * | 1997-12-17 | 1999-09-07 | Ranbaxy Laboratories Limited | Modified release matrix formulation of cefaclor and cephalexin |
| FR2785538B1 (fr) | 1998-11-06 | 2004-04-09 | Prographarm Laboratoires | Comprime a delitement rapide perfectionne |
| EP1005863A1 (en) * | 1998-12-04 | 2000-06-07 | Synthelabo | Controlled-release dosage forms comprising a short acting hypnotic or a salt thereof |
| FR2787715B1 (fr) * | 1998-12-23 | 2002-05-10 | Synthelabo | Composition pharmaceutique comprenant un compose hypnotique ou un de ses sels pharmaceutiquement acceptables |
| FR2790387B1 (fr) | 1999-03-01 | 2001-05-18 | Prographarm Laboratoires | Comprime orodispersible presentant une faible friabilite et son procede de preparation |
| WO2001058424A1 (en) * | 2000-02-09 | 2001-08-16 | West Pharmaceutical Services Drug Delivery & Clinical Research Centre Limited | Floating drug delivery composition |
| US6617123B1 (en) * | 2000-06-29 | 2003-09-09 | Jack V. Smith | Method for detection of 4-hydroxybutyric acid and its precursor(s) in fluids |
| ITMI20011446A1 (it) * | 2001-07-06 | 2003-01-06 | Altergon Sa | Composizioni farmaceutiche di principi attivi suscettibili di somministrazione illecita |
| US20030044989A1 (en) * | 2001-09-04 | 2003-03-06 | Guerra Francisco Javier | Apparatus and method for testing a beverage for a clandestine illicit substance |
| FR2829933B3 (fr) * | 2001-09-21 | 2004-03-12 | Ellipse Pharmaceuticals | Procede de fabrication d'un produit pharmaceutique administrable par voie orale avec des agents detrompeurs notamment de gout et produit obtenu |
| FR2829932B1 (fr) * | 2001-09-21 | 2006-11-24 | Ellipse Pharmaceuticals | Procede de fabrication d'un produit pharmaceutique administrable par voie orale avec des agents detrompeurs et produit obtenu |
| FR2831820B1 (fr) | 2001-11-05 | 2004-08-20 | Ethypharm Sa | Comprime orodispersible presentant une grande homogeneite et son procede de preparation |
| US20080102482A1 (en) | 2003-12-19 | 2008-05-01 | Stanley Irwin Grossman | Apparatus for Detecting Drugs in a Beverage |
| WO2008033351A2 (en) * | 2006-09-11 | 2008-03-20 | Theraquest Biosciences, Inc. | Multimodal abuse resistant and extended release formulations |
| JP2009256295A (ja) * | 2008-04-11 | 2009-11-05 | Kosumedei Seiyaku Kk | 化粧用粘着シート |
| JP5059678B2 (ja) * | 2008-04-18 | 2012-10-24 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | 着色固形製剤およびその製造方法 |
| FR2962331B1 (fr) * | 2010-07-06 | 2020-04-24 | Ethypharm | Forme pharmaceutique pour lutter contre la soumission chimique, methode la mettant en oeuvre |
-
2010
- 2010-07-06 FR FR1055490A patent/FR2962550B1/fr active Active
-
2011
- 2011-07-05 CN CN2011800334204A patent/CN103119435A/zh active Pending
- 2011-07-05 US US13/808,807 patent/US20130098286A1/en not_active Abandoned
- 2011-07-05 WO PCT/FR2011/051600 patent/WO2012010765A1/fr not_active Ceased
- 2011-07-05 KR KR1020137003073A patent/KR20130091321A/ko not_active Ceased
- 2011-07-05 MX MX2012015103A patent/MX344783B/es active IP Right Grant
- 2011-07-05 JP JP2013517480A patent/JP5916723B2/ja active Active
- 2011-07-05 CA CA2802402A patent/CA2802402A1/fr not_active Abandoned
- 2011-07-05 ES ES11743099.1T patent/ES2609831T3/es active Active
- 2011-07-05 EP EP11743099.1A patent/EP2591350B1/fr active Active
- 2011-07-05 AU AU2011281482A patent/AU2011281482B2/en active Active
- 2011-07-05 KR KR1020187019307A patent/KR101957657B1/ko active Active
-
2012
- 2012-12-25 IL IL223886A patent/IL223886B/en active IP Right Grant
-
2013
- 2013-01-04 ZA ZA2013/00099A patent/ZA201300099B/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20230115025A1 (en) | Gastro-retentive drug delivery system | |
| US10525010B2 (en) | Aqueous dispersions of controlled release polymers and shells and capsules thereof | |
| ES2739888T3 (es) | Composiciones y comprimidos farmacéuticos con recubrimiento compresible y métodos de fabricación | |
| JP6219836B2 (ja) | 耐酸性ツーピースハードカプセル用の耐酸性バンディング溶液 | |
| JP2013530206A5 (enExample) | ||
| EP2632584B1 (en) | A process for the manufacture of bulk enteric capsule shells | |
| Jones et al. | The disintegration behaviour of capsules in fed subjects: a comparison of hypromellose (carrageenan) capsules and standard gelatin capsules | |
| US20180078503A1 (en) | Gastro-retentive drug delivery system | |
| ES2877058T3 (es) | Composiciones farmacéuticas resistentes al abuso | |
| KR20150043497A (ko) | 약제 함유 할로우 입자 | |
| Sugihara et al. | Development of a gastric retentive system as a sustained-release formulation of pranlukast hydrate and its subsequent in vivo verification in human studies | |
| Sharma et al. | Design, Development, and Optimization of Polymeric Based‐Colonic Drug Delivery System of Naproxen | |
| Drechsler et al. | Development and evaluation of chitosan and chitosan/Kollicoat® Smartseal 30 D film-coated tablets for colon targeting | |
| JP6780412B2 (ja) | コーティング組成物ならびにコーティング製剤及びその製造方法 | |
| JP6944822B2 (ja) | 易服用性カプセル | |
| JP6294457B2 (ja) | 低減した送達変動性のための複数の投薬要素を備えるメサラミン医薬組成物 | |
| US9827199B2 (en) | Hydromorphone hydrochloride-containing oral sustained-release pharmaceutical composition | |
| Maraie et al. | Application of the new oroslippery technology in the preparation of enteric slippery coated tablet of naproxen | |
| WO2012131476A1 (en) | Composition and method for controlling release of active ingredient | |
| Sudarshan et al. | Colon specific drug delivery system of mesalamine for eradication of ulcerative colitis | |
| Adeyeye et al. | Hard Shell Capsules in Clinical Trials | |
| JP2013533874A5 (enExample) | ||
| Gohel et al. | A novel colonic drug delivery system of ibuprofen | |
| JP2025527331A (ja) | 速溶性ソフトゲルカプセル | |
| Chavda et al. | Formulation & Evaluation of Fast Disintegrating tablet of Nimesulide |